SCHEDULE: Rosalind Advisors Discloses PolyPid Stake

Rosalind Advisors Inc. and related entities report beneficial ownership of 9.9% of PolyPid Ltd. common stock, primarily through warrants.

Summary

• Rosalind Advisors Inc., Rosalind Master Fund L.P., Steven Salamon, and Gilad Aharon have jointly filed a Schedule 13G, indicating beneficial ownership of 9.9% of PolyPid Ltd.'s common stock.
• The total reported beneficial ownership is 5,384,813 shares, which includes 597,926 directly held shares and 4,786,887 shares issuable upon exercise of warrants.
• The filing notes that the exercise of warrants is subject to a 'blocker' provision, preventing exercise if it would result in beneficial ownership exceeding 9.99% of the common stock. As of the filing date, this blocker prevented the exercise of any warrants.
• The percentage of class represented by the reported amount is 9.9%, based on 18,204,002 ordinary shares outstanding as of December 31, 2025, according to a PolyPid Ltd. press release dated February 11, 2026.
• Rosalind Advisors Inc. acts as the investment advisor to Rosalind Master Fund L.P., and Steven Salamon is the portfolio manager for Rosalind Advisors Inc. Both may be deemed beneficial owners of shares held by the fund, though they disclaim beneficial ownership.
• The filing date for this statement is March 31, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it is a routine disclosure of beneficial ownership and does not provide new operational or financial performance information about PolyPid Ltd.

Positives

• Rosalind Advisors and its affiliates hold a significant stake (9.9%) in PolyPid Ltd., indicating confidence in the company's prospects.
• The direct ownership of 597,926 shares demonstrates a tangible investment in the company's current equity.

Negatives

• The significant portion of the reported stake (4,786,887 shares) is tied up in warrants that cannot be exercised due to 'blocker' provisions, limiting immediate control or influence.
• The disclaimer of beneficial ownership by Rosalind Advisors Inc. and Steven Salamon suggests a nuanced or indirect control over the reported shares.

Risks

• The 'blocker' provision on warrants poses a risk of not being able to exercise these securities if beneficial ownership would exceed 9.99%, potentially limiting upside participation or strategic options.
• The reliance on a press release from February 11, 2026, for outstanding share count means the 9.9% calculation is based on potentially outdated information.
• The indirect nature of ownership through an investment advisor and fund structure introduces complexity and potential governance risks.

Future Outlook

The filing does not contain forward-looking statements or guidance from PolyPid Ltd. It is a disclosure of beneficial ownership.

Management Comments

• Rosalind Advisors Inc. is the investment advisor to RMF and may be deemed to be the beneficial owner of shares held by RMF.
• Steven Salamon is the portfolio manager of the Advisor and may be deemed to be the beneficial owner of shares held by RMF.
• Notwithstanding the foregoing, the Advisor and Mr. Salamon disclaim beneficial ownership of the shares.
• The securities reported show the number of shares of Common Stock that would be issuable upon full conversion and exercise of such reported securities and do not give effect to such blockers. Therefore, the actual number of shares of Common Stock beneficially owned by such Reporting Person, after giving effect to such blockers, is less than the number of securities reported.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and funds accumulating significant stakes in public companies. The presence of warrant-based ownership and blocker provisions is a strategic maneuver often employed to manage ownership limits and potential future upside without immediately triggering reporting thresholds or control implications.

Stakeholder Impact

• Shareholders: The disclosure indicates a significant investor's interest, which could influence market perception. However, the inability to exercise warrants due to blockers limits immediate impact on control or voting power.
• Management of PolyPid Ltd.: The filing informs management of a substantial beneficial owner, potentially impacting future strategic discussions or board representation considerations.
• Creditors: No direct impact on creditors is indicated by this filing.

Next Steps

• Monitor future filings from Rosalind Advisors Inc. and related entities for any changes in beneficial ownership.
• Observe PolyPid Ltd.'s operational and financial performance, which will ultimately determine the value of the reported stake and warrants.

Key Dates

Keywords

PolyPid Ltd., Schedule 13G, Rosalind Advisors Inc., Rosalind Master Fund L.P., Steven Salamon, Gilad Aharon, Beneficial Ownership, Warrants, Blocker Provision, SEC Filing, Common Stock, Investment Advisor